Šalis: Airija
kalba: anglų
Šaltinis: HPRA (Health Products Regulatory Authority)
CLINDAMYCIN (AS CLINDAMYCIN HYDROCHLORIDE)
Chanelle Animal Health Ltd.
QJ01FF01
CLINDAMYCIN (AS CLINDAMYCIN HYDROCHLORIDE)
150 mg/tablet
Tablets
POM
Canine
Clindamycin
Antibacterial
Authorised
1999-11-26
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Clinacin 150mg Tablets for Dogs. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains: ACTIVE SUBSTANCE: Clindamycin 150 mg (as clindamycin hydrochloride) EXCIPIENT: For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Tablet. An oblong white tablet, with a break-line on one side. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For the treatment of:- Infected wounds, abscesses and oral cavity/dental infections caused by or associated with clindamycin-sensitive species of; • _Staphylococcus _spp. • _Streptococcus _spp. • _Bacteroides _spp. • _Fusobacterium necrophorum_ • _Clostridium perfringens_ Osteomyelitis • _Staphylococcus aureus_ 4.3 CONTRAINDICATIONS Do not use in cases of known hypersensitivity to clindamycin or lincomycin. Do not administer to rabbits, hamsters, guinea pigs, chinchillas, horses or ruminants because ingestion of clindamycin by these species may result in severe gastro-intestinal disturbance. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None. 4.5 SPECIAL PRECAUTIONS FOR USE HEALTH PRODUCTS REGULATORY AUTHORITY ________________________________________________________________________________________________________________________ _Date Printed 08/11/2016_ _CRN 7024937_ _page number: 1_ SPECIAL PRECAUTIONS FOR USE IN ANIMALS During prolonged therapy of one month or greater, periodic liver and kidney function tests and blood counts should be performed. Patients with severe renal and/or hepatic disturbances accompanied by severe metabolic aberrations should be dosed with caution and should be monitored by serum examination during clindamycin therapy. SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE VETERINARY MEDICINAL PRODUCT Perskaitykite visą dokumentą